C O R R E C T I O N -- AGOURON PHARMACEUTICALS.
/C O R R E C T I O N -- AGOURON PHARMACEUTICALS/ In SD001, Agouron Pharmaceuticals, moved earlier today, we are
advised by the company that the fourth paragraph should read, "Cohen will replace Theodor Heinrichs, who has retired from Agouron's board of directors after six years of service" instead of "...after eight years of service" as originally issued.
-0- 3/19/92 C SD001 (AGPH) CO: Agouron Pharmaceuticals Inc. ST: California IN: MTC SU: PER
CH -- SD001X -- 9621 03/19/92 11:16 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 19, 1992|
|Previous Article:||AT&T ANNOUNCES NEW LONG-DISTANCE SERVICE FOR AMERICANS TRAVELING OR LIVING ABROAD|
|Next Article:||RECESSION THREATENS ENVIRONMENTAL CLEANUP EFFORTS; ENVIRONMENTAL BUSINESS EXECUTIVES GATHER TO SHARE STRATEGIES FOR SUCCESS|